alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002     I, Edward F. Feighan, Chairman of the Board, President and Chief Executive Officer ofProCentury Corporation (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Actof 2002, that:(1) the quarterly report on Form 10-Q of the Company for the period ended June 30, 2006 whichthis certification accompanies fully complies with the requirements of Section 13(a) or 15(d)of the Securities Exchange Act of 1934; and (2) the information contained in the quarterly report fairly presents, in all material respects,the financial condition and results of operations of the Company.   /s/ Edward F. Feighan     Edward F. Feighan  Chairman of the Board, President and Chief Executive Officer  August 7, 2006  
40
SMITH BARNEY
                MASSACHUSETTS MUNICIPALS FUND
                        (the "Fund")
                              
                  Supplement to Prospectus
                   dated January 29, 1995
                              
                              
       Beginning  on  July  1,  1995,  dividends  from   net
investment income will ordinarily be paid by the Fund on the
last  Friday of each month, to shareholders of record as  of
the preceding Tuesday.


Supplement dated January 23, 1996

FD01082 1/96
Exhibit 32


                                CERTIFICATION OF
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


I, Brian Jaggard, Chief Financial Officer, President and Chief Executive Officer
of YZAPP INTERNATIONAL INC. (the "Company"), hereby certify pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that, to the best of my knowledge:

     (i)  the Quarterly Report on Form 10-QSB of the Company, for the fiscal
          quarter ended January 31, 2006, and to which this certification is
          attached as Exhibit 32 (the "Report") fully complies with the
          requirements of Section 13(a) or 15(d) of the Securities Exchange Act
          of 1934, as amended; and

     (ii) the information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.

                                          By:      /s/ Brian Jaggard
                                                   ------------------

                                          Name:    Brian Jaggard

                                          Title:   CHIEF FINANCIAL OFFICER
                                                   PRESIDENT and
                                                   CHIEF EXECUTIVE OFFICER

                                          Date:    March 20, 2006
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE> 6
<CIK> 0000797480
<NAME> Smith Barney Natural Resources Fund
<SERIES>
   <NUMBER>001
   <NAME>Smith Barney Sector Series Inc.

<S>                         <C>
<PERIOD-TYPE>              Year
<FISCAL-YEAR-END>                 Oct-31-2001
<PERIOD-END>                      Oct-31-2000
<INVESTMENTS-AT-COST>              30,963,082
<INVESTMENTS-AT-VALUE>             35,234,998
<RECEIVABLES>                          13,928
<ASSETS-OTHER>                      1,867,783
<OTHER-ITEMS-ASSETS>                        0
<TOTAL-ASSETS>                     37,116,709
<PAYABLE-FOR-SECURITIES>                    0
<SENIOR-LONG-TERM-DEBT>                     0
<OTHER-ITEMS-LIABILITIES>           1,867,671
<TOTAL-LIABILITIES>                 1,867,671
<SENIOR-EQUITY>                             0
<PAID-IN-CAPITAL-COMMON>           49,189,850
<SHARES-COMMON-STOCK>                 853,959
<SHARES-COMMON-PRIOR>               1,318,953
<ACCUMULATED-NII-CURRENT>               4,416
<OVERDISTRIBUTION-NII>                      0
<ACCUMULATED-NET-GAINS>           (18,217,144)
<OVERDISTRIBUTION-GAINS>                    0
<ACCUM-APPREC-OR-DEPREC>            4,271,916
<NET-ASSETS>                       35,249,038
<DIVIDEND-INCOME>                     727,281
<INTEREST-INCOME>                      37,079
<OTHER-INCOME>                              0
<EXPENSES-NET>                        898,014
<NET-INVESTMENT-INCOME>              (133,654)
<REALIZED-GAINS-CURRENT>           (4,223,990)
<APPREC-INCREASE-CURRENT>           5,553,665
<NET-CHANGE-FROM-OPS>               1,196,021
<EQUALIZATION>                              0
<DISTRIBUTIONS-OF-INCOME>                   0
<DISTRIBUTIONS-OF-GAINS>                    0
<DISTRIBUTIONS-OTHER>                       0
<NUMBER-OF-SHARES-SOLD>               298,227
<NUMBER-OF-SHARES-REDEEMED>           763,221
<SHARES-REINVESTED>                         0
<NET-CHANGE-IN-ASSETS>            (12,738,115)
<ACCUMULATED-NII-PRIOR>                 4,896
<ACCUMULATED-GAINS-PRIOR>         (15,316,808)
<OVERDISTRIB-NII-PRIOR>                     0
<OVERDIST-NET-GAINS-PRIOR>                  0
<GROSS-ADVISORY-FEES>                 326,909
<INTEREST-EXPENSE>                          0
<GROSS-EXPENSE>                       898,014
<AVERAGE-NET-ASSETS>               20,279,143
<PER-SHARE-NAV-BEGIN>                  18.150
<PER-SHARE-NII>                        (0.120)
<PER-SHARE-GAIN-APPREC>                 0.360
<PER-SHARE-DIVIDEND>                    0.000
<PER-SHARE-DISTRIBUTIONS>               0.000
<RETURNS-OF-CAPITAL>                    0.000
<PER-SHARE-NAV-END>                    18.390
<EXPENSE-RATIO>                          2.38



</TABLE>
EXHIBIT 31.1
------------

                                  CERTIFICATION

         I, Theodore G. Hollinger, Chief Executive Officer, certify that:

         1. I have  reviewed  this  quarterly  report on Form 10-QSB of Hydrogen
         Engine Center, Inc.;

         2. Based on my  knowledge,  this  report  does not  contain  any untrue
         statement of a material fact or omit to state a material fact necessary
         to make the statements made, in light of the circumstances  under which
         such  statements  were made, not misleading  with respect to the period
         covered by this report;

         3. Based on my knowledge, the financial statements, and other financial
         information  included in this  report,  fairly  present in all material
         respects the financial condition,  results of operations and cash flows
         of the registrant as of, and for, the periods presented in this report;

         4. The  registrant's  other  certifying  officer and I have  disclosed,
         based on our most recent  evaluation of internal control over financial
         reporting,  to the registrant's auditors and the audit committee of the
         registrant's  board of directors (or persons  performing the equivalent
         functions):

                  a. All significant deficiencies and material weaknesses in the
                  design  or  operation  of  internal   control  over  financial
                  reporting which are reasonably  likely to adversely affect the
                  registrant's ability to record, process,  summarize and report
                  financial information; and

                  b.  Any  fraud,   whether  or  not  material,   that  involves
                  management or other  employees who have a significant  role in
                  the registrant's internal control over financial reporting.

 May 19, 2006                                  /s/ Theodore G. Hollinger
                                               ---------------------------------
                                                   Theodore G. Hollinger
                                                   Chief Executive Officer
[Cite as Keith v. Kelley, 125 Ohio St.3d 161, 2010-Ohio-1807.]

K EITH , A PPELLANT , v. K ELLEY , W ARDEN , A PPELLEE . [Cite as Keith v. Kelley, 125 Ohio St.3d 161, 2010-Ohio-1807.] Appeal from dismissal of a petition for a writ of habeas corpus — Res judicata bars petitioner from filing a su ccessive habeas corpus petition — Adequate remedy at law — Judgment affirmed. (No. 2010-0037

─ Submitted April 20, 2010

─ Decided April 28, 2010.)
A PPEAL from the Court of Appeals for Trumbull County, No. 2009-T-0056, 2009-Ohio-6711.

__________________ Per Curiam. {¶ 1} We affirm the judgment dismissing the petition of appellant, Jeffrey C. Keith, for a writ of habeas corpus . Res judicata bars Keith from filing a successive habeas corpus petition insofar as he raises claims that he either raised or could have raised in his previous petition. Amstutz v. Eberlin , 119 Ohio St.3d 421, 2008-Ohio-4538, 894 N.E.2d 1219, ¶ 7; Keith v. Bobby , 117 Ohio St.3d 470, 2008-Ohio-1443, 884 N.E.2d 1067. Moreover, as the court of appeals held, Keith’s initial sentence is not void and has not expired, and he has or had an adequate remedy by appeal to raise his claims that the tria l court judges were improperly assigned to his criminal cases. See Keith , at ¶ 12, 14. Judgment affirmed.
P FEIFER , A CTING C.J., and L UNDBERG S TRATTON , O’C ONNOR , O’D ONNELL , L ANZINGER , and C UPP , JJ., concur.
The late C HIEF J USTICE T HOMAS J. M OYER did not participate in the
decision in this case.

__________________ Jeffrey C. Keith, pro se.S UPREME C OURT OF O HIO

2 Richard Cordray, Attorney Genera l, and M. Scott Criss, Assistant Attorney General, for appellee.

__________________
Exhibit
32.1

CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO 
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In
connection with the Quarterly Report of Community Banks of Georgia, Inc. (the
Company) on Form 10-QSB for the period ending March 31, 2004 as filed with
the Securities and Exchange Commission on the date hereof (the Report), I,
John T. Trammell, Chief Executive Officer of the Company, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that the Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934,
and the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

This13th day of May 2004.

|/s/ John T. Trammell    | 
|----------------------- | 
|                        | 
|John T. Trammell        | 
|Chief Executive Officer | 

- 18 -

---

---
[Federal Register Volume 87, Number 117 (Friday, June 17, 2022)]
[Notices]
[Pages 36519-36520]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-13064]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; SUNBEAM--Analysis and 
Bioinformatics Center (ABC) (UM1 Clinical Trial Not Allowed).
    Date: July 19, 2022.
    Time: 9:00 a.m. to 5:30 p.m.

[[Page 36520]]

    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3F52, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Lindsey M. Pujanandez, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3F52, 
Rockville, MD 20852, (240) 627-3206, <a href="/cdn-cgi/l/email-protection#d8b4b1b6bcabbda1f6a8adb2b9b6b9b6bcbda298b6b1b0f6bfb7ae"><span class="__cf_email__" data-cfemail="c7abaea9a3b4a2bee9b7b2ada6a9a6a9a3a2bd87a9aeafe9a0a8b1">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: June 13, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-13064 Filed 6-16-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# Official Journal L 34I/2023

| | ISSN 1977-0677 |
| --- | --- |
| Official Journal
  of the European Union | L 034I |
| | |
| English edition | Legislation | Volume 666 February 2023 |

ISSN 1977-0677

Official Journal

of the European Union

L 034I

English edition

Legislation

Volume 666 February 2023

---

| Contents | | II   Non-legislative acts | page |
| --- | --- | --- | --- |
| | | REGULATIONS |
| | * | Commission Implementing Regulation (EU) 2023/249 of 3 February 2023 amending for the 333rd time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da’esh) and Al-Qaida organisations | 1 |

Contents

II   Non-legislative acts

page

REGULATIONS

*

Commission Implementing Regulation (EU) 2023/249 of 3 February 2023 amending for the 333rd time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da’esh) and Al-Qaida organisations

1

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
---

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS
ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Robert Tick, Chief Financial Officer of
NUTRASTAR INTERNATIONAL INC. (the Company), DOES HEREBY CERTIFY that:

1.     The Companys Quarterly Report on Form 10-Q for the quarter
ended March 31, 2011 (the Report), fully complies with the requirements of
Section 13(a) of the Securities Exchange Act of 1934; and

2.     Information contained in the Report fairly presents, in all
material respects, the financial condition and results of operation of the
Company.

IN WITNESS WHEREOF, each of the undersigned has executed this
statement this 16thday of May 2011.

/s/ Robert
TickRobert Tick Chief Financial Officer(Principal Financial
Officer and Accounting Officer)

A signed original of this written statement required by Section
906 has been provided to Nutrastar International Inc. and will be retained by
Nutrastar International Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.

The forgoing certification is being furnished to the Securities
and Exchange Commission pursuant to § 18 U.S.C. Section 1350. It is not being
filed for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended, and is not to be incorporated by reference into any filing of the
Company, whether made before or after the date hereof, regardless of any general
incorporation language in such filing.

---
**Exhibit
      32.2**








**CERTIFICATION
      PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**











In
      connection with the Quarterly Report of Community Banks of Georgia,
      Inc.  (the
      “Company”) on Form 10-QSB for the period ending June 30, 2005 as filed with the
      Securities and Exchange Commission on the date hereof (the “Report”), I, Frank
      N. Eubanks, Chief Financial Officer of the Company, certify, pursuant to 18
      U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
      Act of 2002, that the Report fully complies with the requirements of Section
      13(a) or 15(d) of the Securities Exchange Act of 1934, and the information
      contained in the Report fairly presents, in all material respects, the financial
      condition and results of operations of the Company.





This
      15 th day of
      August, 2005.

















/s/
      Frank N. Eubanks


Frank
      N.
      Eubanks


Chief
      Financial Officer
Exhibit 34.17

 

|  |   |  |
|--|--------|--|

 

Report of Independent Registered Public Accounting Firm

To CWCapital Asset Management LLC

We have examined management of CWCapital Asset Management LLC ("CWCAM")'s assertion that CWCAM complied with the servicing criteria set forth in Item 1122(d) of the U.S. Securities and Exchange Commission ("SEC")'s Regulation AB for the commercial mortgage-backed securitization trusts included in the accompanying Management's Assertion on Compliance with Regulation AB Criteria as of and for the year ended December 31, 2019. CWCAM's management is responsible for its assertion. Our responsibility is to express an opinion on management's assertion about CWCAM's compliance with the specified requirements based on our examination.

Management has determined that the criteria set forth in Sections 1122 (d)(1)(iii), (d)(3)(i)(B), (d)(3)(i)(C), (d)(3)(i)(D), (d)(3)(ii), (d)(3)(iii), (d)(3)(iv), (d)(4)(v), (d)(4)(ix), (d)(4)(x), (d)(4)(xi), (d)(4)(xii), (d)(4)(xiii), (d)(4)(xiv), and (d)(4)(xv) are not applicable to the activities performed by CWCAM, as a special servicer, with respect to CWCAM's Platform. The commercial mortgage-backed securities transactions covered by this Platform are those specified in Appendix B in the accompanying Management's Assertion on Compliance with Regulation AB Criteria.

Our examination was conducted in accordance with attestation standards established by the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the examination to obtain reasonable assurance about whether management's assertion about compliance with the specified requirements is fairly stated, in all material respects. An examination involves performing procedures to obtain evidence about whether management's assertion is fairly stated, in all material respects. The nature, timing, and extent of the procedures selected depend on our judgment, including an assessment of the risks of material misstatement of management's assertion, whether due to fraud or error. We believe that the evidence we obtained is sufficient and appropriate to provide a reasonable basis for our opinion.

Our examination does not provide a legal determination on CWCAM's compliance with the specified requirements.

In our opinion, management's assertion that CWCAM complied with the servicing criteria set forth in Item 1122(d) of the U.S. SEC's Regulation AB for the commercial mortgage-backed securitization trusts included in the accompanying Management's Assertion on Compliance with Regulation AB Criteria is fairly stated, in all material respects.

/s/CohnReznick LLP

Bethesda, Maryland February 25, 2020

(Except for Assertion 3 on the Management’s Assertion on

Compliance with Regulation AB Criteria for which is dated

March 23, 2020)
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4869 Introduced in House (IH)]

110th CONGRESS
  1st Session
                                H. R. 4869

          To extend the temporary suspension of duty on 4-[(4-
                 Aminophenyl)azo]benzenesulfonic acid.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           December 19, 2007

   Mr. Clay introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
          To extend the temporary suspension of duty on 4-[(4-
                 Aminophenyl)azo]benzenesulfonic acid.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 4-[(4-AMINOPHENYL)AZO]BENZENESULFONIC ACID.

    (a) In General.--Heading 9902.02.41 of the Harmonized Tariff 
Schedule of the United States is amended by striking ``12/31/2009'' and 
inserting ``12/31/2011''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
Richard Wayne TAYLOR, Petitioner, v. TEXAS.

No. 19-7808.

Supreme Court of the United States.

April 27, 2020

Petition for writ of certiorari to the Court of Criminal Appeals of Texas denied.
STATE v. ROBINSON.

No. COA03-1201.

Court of Appeals of North Carolina.

Filed September 7, 2004.

Certification Date September 27, 2004.

Case reported without published opinion. No error in part. Arrest judgment as to felonious assault inflicting serious bodily injury, case no. 03CRS3972.
# C_2004213EN.01001001.xml

| 25.8.2004 | EN | Official Journal of the European Union | C 213/10 |
| --- | --- | --- | --- |

25.8.2004

EN

Official Journal of the European Union

C 213/10

---

Corrigendum to the general budget of the European Union for the financial year 2004 (EU-25)

(
  Official Journal of the European Union C 105 of 30 April 2004
  )

(
  Official Journal of the European Union C 105 of 30 April 2004

(2004/C 213/05)

In Section III: Commission, Volume II, pages 931 and 934, in Item 17 01 04 03 and Article 17 02 01 respectively, at the end of the Remarks, the following paragraph should be added:

‘Any revenue from the candidate countries' contribution to participation in Community programmes, entered in Item 6 0 9 1 of the statement of revenue, may give rise to the provision of additional appropriations, according to the same ratio as between the amount authorised for expenditure on administrative management and the total appropriations entered for the programme, pursuant to Article 18(1)(d) of the Financial Regulation.’

---
**CERTIFICATION
      OF CHIEF EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION
      1350,**


**AS
      ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF
      2002**





Pursuant
      to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002, in connection with the filing of the Quarterly
      Report on Form 10-QSB for the fiscal year ended March 31, 2007 (the “Report”) by
      China Fire & Security Group, Inc. (the “Registrant”), I, Brian Lin, hereby
      certify that:





1.
      To the
      best of my knowledge, the Report fully complies with the requirements of Section
      13(a) or 15(d) of the Securities Exchange Act of 1934; and





2.
      To the
      best of my knowledge, the information contained in the Report fairly presents,
      in all material respects, the financial condition and results of operations
      of
      the Registrant.




Dated:
                May 15, 2007
            By:
            /s/
                Brian LinName:Brian
                LinTitle:  
                Principal Accounting Officer